Glucose Health
OTC: GLUCBentonville, US · Delaware corporation
Founders & leadership
FF
Fleming FlemingExecutive
MS
Mark SchaftleinCEO and Director of Issuer
MH
Marc HatchExecutive
MF
Murray FlemingNamed on SEC filing
Board
EB
Edmund BurkeBoard director
CJ
Chris JemapeteBoard director
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 8 rounds · 2019–2026
▶$60KraisedJul 2026 · 1 investors · ManufacturingRule 506(b)
▶$60KraisedJul 2026 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Mark SchaftleinDirector
- Marc HatchExecutive Officer
- Chris JemapeteDirector
- Edmund BurkeDirector
- Offering amount
- $120K
- Amount sold
- $60K
- Minimum investment
- $60K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedFeb 2026 · 1 investors · ManufacturingRule 506(b)
▶$100KraisedFeb 2026 · 1 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Marc HatchExecutive Officer
- Mark SchaftleinExecutive Officer, Director
- Chris JemapeteDirector
- Edmunc burkeDirector
- Offering amount
- $100K
- Amount sold
- $100K
- Minimum investment
- $100K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20KraisedDec 2025 · 2 investors · ManufacturingRule 506(b)
▶$20KraisedDec 2025 · 2 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Edmund BurkeDirector
- Fleming FlemingDirector
- Chris JemapeteDirector
- Mark SchaftleinExecutive Officer, Director
- Marc HatchExecutive Officer
- Offering amount
- $20K
- Amount sold
- $20K
- Minimum investment
- $10K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$290KraisedJan 2024 · 5 investors · ManufacturingRule 506(b)
▶$290KraisedJan 2024 · 5 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Murray FlemingExecutive Officer, Director
- Offering amount
- $290K
- Amount sold
- $290K
- Minimum investment
- $15K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$960KraisedMar 2021 · 10 investors · ManufacturingRule 506(b)
▶$960KraisedMar 2021 · 10 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Murray FlemingExecutive Officer, Director
- Hal KravitzDirector
- Gerry DavidDirector
- John FieldlyDirector
- Offering amount
- $960K
- Amount sold
- $960K
- Minimum investment
- $25K
- First sale
- Feb 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$300KraisedJun 2020 · 8 investors · ManufacturingRule 506(b)
▶$300KraisedJun 2020 · 8 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Hal KravitzDirector
- Gerry DavidDirector
- John FieldlyDirector
- Murray FlemingExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Jun 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$65KraisedMay 2020 · 4 investors · ManufacturingRule 506(b)
▶$65KraisedMay 2020 · 4 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Murray FlemingExecutive Officer
- Offering amount
- $65K
- Amount sold
- $65K
- First sale
- May 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$460KraisedMay 2019 · 4 investors · ManufacturingRule 506(b)
▶$460KraisedMay 2019 · 4 investors · Manufacturing
Rule 506(b)Officers, directors & promoters on the filing
- Murray FlemingExecutive Officer
- Offering amount
- $460K
- Amount sold
- $460K
- First sale
- May 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Glucose Health raised?
- Glucose Health has disclosed $2.3M raised across 8 rounds.
- Where is Glucose Health headquartered?
- Glucose Health is headquartered in Bentonville, US.